The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Optimal implantation is the way to prevent scaffold thrombosis: a hypothesis to be tested

EuroIntervention 2017;13:e142-e144 published online ahead of print May 2017 published online e-edition June 2017. DOI: 10.4244/EIJV13I2A19

Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy

With the development and implementation into clinical practice of newer drug-eluting stents (DES), stent thrombosis (ST) rates have consistently been decreasing. This is because current platforms are manufactured with thin struts in combination with drug delivery systems promoting rapid endothelialisation, and they are therefore more forgiving in terms of procedural optimisation. However, with the advent of bioresorbable scaffolds (BRS), a paradigm shift has taken place. Due to their lower radial strength, BRS require thorough lesion preparation as well as systematic post-dilatation to achieve an adequate result. Their thicker and wider struts result in greater protrusion into the vessel lumen, ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Coronary physiological parameters at a crossroads